84 related articles for article (PubMed ID: 26484297)
1. Deep sequencing of mRNA in CD24(-) and CD24(+) mammary carcinoma Mvt1 cell line.
Rostoker R; Jayaprakash AD; Sachidanandam R; LeRoith D
Genom Data; 2015 Sep; 5():399-401. PubMed ID: 26484297
[TBL] [Abstract][Full Text] [Related]
2. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
3. CD24(+) cells fuel rapid tumor growth and display high metastatic capacity.
Rostoker R; Abelson S; Genkin I; Ben-Shmuel S; Sachidanandam R; Scheinman EJ; Bitton-Worms K; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Breast Cancer Res; 2015 Jun; 17(1):78. PubMed ID: 26040280
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24.
Schindelmann S; Windisch J; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Tumour Biol; 2002; 23(3):139-45. PubMed ID: 12218294
[TBL] [Abstract][Full Text] [Related]
5. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
[TBL] [Abstract][Full Text] [Related]
6. Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth.
Ben-Shmuel S; Rashed R; Rostoker R; Isakov E; Shen-Orr Z; LeRoith D
Front Endocrinol (Lausanne); 2017; 8():173. PubMed ID: 28785242
[TBL] [Abstract][Full Text] [Related]
7. Mammary Epithelial Cell Lineage Changes During Cow's Life.
Finot L; Chanat E; Dessauge F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):185-197. PubMed ID: 30758700
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma.
Farid RM; Sammour SA; Shehab ElDin ZA; Salman MI; Omran TI
Cancer Manag Res; 2019; 11():4677-4690. PubMed ID: 31213893
[No Abstract] [Full Text] [Related]
9. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
10. CD24⁺ ovary cancer cells exhibit an invasive mesenchymal phenotype.
Kang KS; Choi YP; Gao MQ; Kang S; Kim BG; Lee JH; Kwon MJ; Shin YK; Cho NH
Biochem Biophys Res Commun; 2013 Mar; 432(2):333-8. PubMed ID: 23396061
[TBL] [Abstract][Full Text] [Related]
11. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
12. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
14. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
15. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
16. Expression of a B-cell marker, CD24, on nasopharyngeal carcinoma cells.
Karran L; Jones M; Morley G; van Noorden S; Smith P; Lampert I; Griffin BE
Int J Cancer; 1995 Feb; 60(4):562-6. PubMed ID: 7829271
[TBL] [Abstract][Full Text] [Related]
17. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
18. CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.
Tanaka T; Terai Y; Kogata Y; Ashihara K; Maeda K; Fujiwara S; Yoo S; Tanaka Y; Tsunetoh S; Sasaki H; Kanemura M; Tanabe A; Ohmichi M
Oncol Rep; 2015 Nov; 34(5):2282-8. PubMed ID: 26351781
[TBL] [Abstract][Full Text] [Related]
19. Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44(+)/CD24(-/low) Stem Cell Phenotype.
Gao X; Sishc BJ; Nelson CB; Hahnfeldt P; Bailey SM; Hlatky L
Front Oncol; 2016; 6():138. PubMed ID: 27379202
[TBL] [Abstract][Full Text] [Related]
20. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
Huang LR; Hsu HC
Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
